Bank of America’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-97,803
| Closed | -$93.9K | – | 8127 |
|
|
2023
Q2 | $93.9K | Sell |
97,803
-196,709
| -67% | -$194K | ﹤0.01% | 6228 |
|
|
2023
Q1 | $221K | Buy |
294,512
+140,042
| +91% | +$102K | ﹤0.01% | 5871 |
|
|
2022
Q4 | $56.8K | Sell |
154,470
-645,344
| -81% | -$272K | ﹤0.01% | 6432 |
|
|
2022
Q3 | $344K | Buy |
799,814
+716,259
| +857% | +$704K | ﹤0.01% | 5648 |
|
|
2022
Q2 | $65K | Buy |
83,555
+11,558
| +16% | +$10.2K | ﹤0.01% | 6711 |
|
|
2022
Q1 | $92K | Sell |
71,997
-6,822,659
| -99% | -$6.28M | ﹤0.01% | 6913 |
|
|
2021
Q4 | $8.76M | Buy |
6,894,656
+6,763,746
| +5,167% | +$12.1M | ﹤0.01% | 3065 |
|
|
2021
Q3 | $285K | Sell |
130,910
-257,463
| -66% | -$703K | ﹤0.01% | 6045 |
|
|
2021
Q2 | $1.46M | Sell |
388,373
-221,276
| -36% | -$769K | ﹤0.01% | 4583 |
|
|
2021
Q1 | $1.99M | Buy |
609,649
+259,427
| +74% | +$930K | ﹤0.01% | 4266 |
|
|
2020
Q4 | $1.19M | Sell |
350,222
-220,951
| -39% | -$909K | ﹤0.01% | 4360 |
|
|
2020
Q3 | $2.33M | Buy |
571,173
+313,359
| +122% | +$1.19M | ﹤0.01% | 3547 |
|
|
2020
Q2 | $872K | Buy |
257,814
+29,749
| +13% | +$86.7K | ﹤0.01% | 4217 |
|
|
2020
Q1 | $532K | Sell |
228,065
-15,154
| -6% | -$41.5K | ﹤0.01% | 4463 |
|
|
2019
Q4 | $885K | Sell |
243,219
-71,790
| -23% | -$580K | ﹤0.01% | 4590 |
|
|
2019
Q3 | $2.61M | Sell |
315,009
-34,091
| -10% | -$276K | ﹤0.01% | 3814 |
|
|
2019
Q2 | $3.01M | Sell |
349,100
-339,239
| -49% | -$3.03M | ﹤0.01% | 3686 |
|
|
2019
Q1 | $7.36M | Buy |
688,339
+502,703
| +271% | +$5.38M | ﹤0.01% | 2785 |
|
|
2018
Q4 | $1.62M | Buy |
185,636
+100,649
| +118% | +$1.28M | ﹤0.01% | 4015 |
|
|
2018
Q3 | $1.43M | Sell |
84,987
-89,033
| -51% | -$1.93M | ﹤0.01% | 4238 |
|
|
2018
Q2 | $3.65M | Buy |
174,020
+48,048
| +38% | +$890K | ﹤0.01% | 3449 |
|
|
2018
Q1 | $2.03M | Sell |
125,972
-289,680
| -70% | -$5.74M | ﹤0.01% | 3876 |
|
|
2017
Q4 | $7.88M | Buy |
415,652
+77,040
| +23% | +$1.4M | ﹤0.01% | 2695 |
|
|
2017
Q3 | $4.76M | Buy |
338,612
+107,673
| +47% | +$974K | ﹤0.01% | 3221 |
|
|
2017
Q2 | $1.72M | Sell |
230,939
-811
| -0.3% | -$5.3K | ﹤0.01% | 4018 |
|
|
2017
Q1 | $1.51M | Buy |
231,750
+79,619
| +52% | +$445K | ﹤0.01% | 4118 |
|
|
2016
Q4 | $674K | Buy |
152,131
+69,502
| +84% | +$292K | ﹤0.01% | 4618 |
|
|
2016
Q3 | $386K | Buy |
82,629
+45,436
| +122% | +$269K | ﹤0.01% | 4792 |
|
|
2016
Q2 | $245K | Buy |
37,193
+11,341
| +44% | +$80.1K | ﹤0.01% | 5103 |
|
|
2016
Q1 | $164K | Sell |
25,852
-9,892
| -28% | -$50.8K | ﹤0.01% | 5241 |
|
|
2015
Q4 | $215K | Buy |
35,744
+9,877
| +38% | +$56.5K | ﹤0.01% | 5336 |
|
|
2015
Q3 | $155K | Sell |
25,867
-100,472
| -80% | -$697K | ﹤0.01% | 5466 |
|
|
2015
Q2 | $864K | Buy |
126,339
+123,944
| +5,175% | +$787K | ﹤0.01% | 4225 |
|
|
2015
Q1 | $15K | Sell |
2,395
-14,184
| -86% | -$94.4K | ﹤0.01% | 6168 |
|
|
2014
Q4 | $115K | Sell |
16,579
-2,599
| -14% | -$19.1K | ﹤0.01% | 5787 |
|
|
2014
Q3 | $157K | Buy |
19,178
+2,391
| +14% | +$18.7K | ﹤0.01% | 5615 |
|
|
2014
Q2 | $137K | Buy |
16,787
+3,011
| +22% | +$22.8K | ﹤0.01% | 5874 |
|
|
2014
Q1 | $109K | Sell |
13,776
-23,829
| -63% | -$202K | ﹤0.01% | 5930 |
|
|
2013
Q4 | $333K | Sell |
37,605
-39,805
| -51% | -$356K | ﹤0.01% | 5133 |
|
|
2013
Q3 | $649K | Sell |
77,410
-16,170
| -17% | -$131K | ﹤0.01% | 4384 |
|
|
2013
Q2 | $699K | Buy |
+93,580
| New | +$718K | ﹤0.01% | 4408 |
|
Bank of America's SPPI Position: Q3 2023 in Review
Bank of America sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 97,803 shares — an estimated $93.9K sold.
Bank of America first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $8.76M in Q4 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Bank of America reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 97,803 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $93.9K.
- Bank of America first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Bank of America's Spectrum Pharmaceuticals Inc position peaked at $8.76M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.